In this Section |
231049 Semiparametric bayesian modeling of spatio-survival data under cure fractionMonday, November 8, 2010
: 12:52 PM - 1:03 PM
We propose the use of Bayesian spatial modeling with cure rates to model colon cancer survival times for patients diagnosed in the state of Connecticut between 1973-2004, and with follow up time until 2007. This research is motivated by the SEER data base, but the proposed work offers useful contributions to general statistical theory and methodology in survival analysis, spatial statistics and cure rates modeling. In recent times, spatial variability components, cure possibilities, and the changes over time of the survival curve have been of paramount interest to researchers and public health decision makers. There has been research addressing each of these factors independently, but there is a need for a richer class of models to enable a comprehensive analysis of time to event data. We assume semi-parametric baseline hazard functions with a grid defined by join-point parameters similar to the ones used in join-point regression models. The hazard model is set up under the generalized proportional hazard framework in which we also include a covariance function. We integrate into the analysis the spatial correlation structure, in the form of county cancer level frailties and the cure rates. Finally, we compare across a broad collection of high-dimensional hierarchical models using the log of the pseudo-marginal likelihood. This paper uses a Bayesian hierarchical model for capturing spatial heterogeneity and cure rates for right censored time to event data under a semiparametric proportional hazard framework. We obtain the usual posterior estimates, smoothed by counties level maps of spatial frailties and cure rates.
Learning Areas:
Biostatistics, economicsLearning Objectives:
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am qualified to present because my work proposes a model that identify changes over time of the hazard and survival curves which could provide valuable information for health
polices makers, specially when analyzing data across a long time period; for example many cancers have an increasing hazard rate after discovery then a decreasing rate after the treatment phase. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3250.0: Student Research Session & Competition
|